Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
1yon MSN
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.
The Independent on MSN
New blood test could reveal if prostate cancer treatment is failing
New blood test could reveal if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early ...
NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results